Continuous Glucose Monitoring Systems Market By Component (Sensors , Transmitters and Receivers ), By Demography (Child Population, Adult Population), By End User (Hospital and Clinics, Home healthcare, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The continuous glucose monitoring systems market was valued at $6,626.6 million in 2021, and is estimated to reach $31,708.2 million by 2031, growing at a CAGR of 17.0% from 2022 to 2031.The continuous glucose monitoring systems (CGMs) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. CGMs are mainly used by patients suffering from hypo and hyperglycemic conditions. There are several different types of CGM systems available in the market, each with its own set of features and benefits such as interstitial fluid CGMs, blood glucose CGMs, and hybrid closed loop CGMs. These systems offer various advantages such as improved glucose control, reduced need for fingerstick testing, increased awareness of glucose patterns, and improved quality of life.
The continuous glucose monitoring systems market growth is driven by increase in number of patients suffering from diabetes; rise in technological advancements such as the development of miniaturized and wearable devices that can provide real-time glucose readings; and increase in patient awareness about be benefits of CGMs. The rise in prevalence of diabetes propels high adoption of CGMs for monitoring glucose levels. The sensor is implanted in the layer of skin which measure glucose levels in the interstitial fluid and a receiver displays the readings. For instance, according to International Diabetes Federation (IDF), about 537 million adults are living with diabetes in 2021, across the globe. In addition, as per the same source, over 3 in 4 adults with diabetes live in low and middle-income countries such as India and China. Thus, rise in the prevalence of diabetes has resulted in increased demand for CGMs, which, in turn, contribute to the market growth.
Furthermore, increase in government initiatives and reimbursement policies are the key factors that boost the market growth. For instance, the Australian Government has implemented the continuous glucose monitoring (CGM) Initiative as part of the National Diabetes Services Scheme (NDSS) to provide access to fully subsidized Dexcom CGMs for eligible people with Type 1 diabetes. This initiative is designed to improve the quality of life for people with Type 1 diabetes and reduce the risk of complications associated with the condition. By providing access to fully subsidized CGMs, the government is helping to make these devices more widely available and accessible to people with Type 1 diabetes. Furthermore, rise in funding activities to conduct the clinical evaluations of CGMs, further contribute towards the market growth. For instance, European Commission's Horizon 2020 program provided funding of $2.85 million for the continued development of non-invasive touch glucose monitoring technology, GlucoBeam. Therefore, such initiatives taken by government supports the company to continue the research and testing of novel CGMs, which, in turn, boost the market growth.
However, the high cost of CGM systems, and complexity of devices limit the adoption of CGMs, which, in turn, restrains the market growth.
On the other hand, increased demand of medical devices in the developed countries such as the U.S., Canada, and rest of world and growth potential in emerging markets expected to create immense opportunities for CGMs during the forecast period.
The continuous glucose monitoring systems market is segmented on the basis of component, demography, end user, and region. On the basis of component, the market is classified into sensors and transmitters & receivers. On the basis of demography, the market is segmented into child population (≤14 years) and adult population (>14 years). On the basis of end user, the market is classified into hospitals & clinics, home healthcare, and others. The others include ambulatory settings and diagnostic center.
Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, Netherlands, Norway, Sweden, Denmark, Finland, and rest of Europe), Asia-Pacific (India, China, Australia, Japan, South Korea, New Zealand, Philippines, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Venezuela, Argentina, and rest of LAMEA).
Major key players that operate in the global continuous glucose monitoring systems market are A. Menarini, Diagnostics S.r.l, Abbott Laboratories, DexCom, Inc., F. Hoffman-La Roche Ltd, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Senseonics, and Ypsomed AG.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the continuous glucose monitoring systems market analysis from 2021 to 2031 to identify the prevailing continuous glucose monitoring systems market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the continuous glucose monitoring systems market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global continuous glucose monitoring systems market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Demography
Child Population
Adult Population
By End User
Home healthcare
Others
Hospital and Clinics
By Component
Transmitters and Receivers
Sensors
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Netherlands
Norway
Sweden
Denmark
Finland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
New Zealand
Philippines
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Venezuela
Argentina
Rest of LAMEA
Key Market Players
Medtronic plc
DexCom, Inc.
Johnson & Johnson
F. Hoffman-La Roche Ltd
GlySens Incorporated
Novo Nordisk A/S
Abbott Laboratories
Senseonics
A. Menarini Diagnostics S.r.l
Ypsomed AG
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in number of people suffering from diabetes
- 3.4.1.2. Benefits of CGMs over conventional glucose monitoring devices
- 3.4.1.3. High adoption rate of CGMs in home healthcare and ICUs
- 3.4.2. Restraints
- 3.4.2.1. Adverse effects associated with CGMs
- 3.4.2.2. High cost of CGMs
- 3.4.3. Opportunities
- 3.4.3.1. High undiagnosed patient population
- 3.4.3.2. Technological advancement in CGMs
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Sensors
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Transmitters and Receivers
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Child Population
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Adult Population
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospital and Clinics
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Home healthcare
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Component
- 7.2.3. Market size and forecast, by Demography
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Component
- 7.2.5.1.3. Market size and forecast, by Demography
- 7.2.5.1.4. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Component
- 7.2.5.2.3. Market size and forecast, by Demography
- 7.2.5.2.4. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Component
- 7.2.5.3.3. Market size and forecast, by Demography
- 7.2.5.3.4. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Component
- 7.3.3. Market size and forecast, by Demography
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Component
- 7.3.5.1.3. Market size and forecast, by Demography
- 7.3.5.1.4. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Component
- 7.3.5.2.3. Market size and forecast, by Demography
- 7.3.5.2.4. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Component
- 7.3.5.3.3. Market size and forecast, by Demography
- 7.3.5.3.4. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Component
- 7.3.5.4.3. Market size and forecast, by Demography
- 7.3.5.4.4. Market size and forecast, by End User
- 7.3.5.5. Russia
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Component
- 7.3.5.5.3. Market size and forecast, by Demography
- 7.3.5.5.4. Market size and forecast, by End User
- 7.3.5.6. Spain
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Component
- 7.3.5.6.3. Market size and forecast, by Demography
- 7.3.5.6.4. Market size and forecast, by End User
- 7.3.5.7. Netherlands
- 7.3.5.7.1. Key market trends, growth factors and opportunities
- 7.3.5.7.2. Market size and forecast, by Component
- 7.3.5.7.3. Market size and forecast, by Demography
- 7.3.5.7.4. Market size and forecast, by End User
- 7.3.5.8. Norway
- 7.3.5.8.1. Key market trends, growth factors and opportunities
- 7.3.5.8.2. Market size and forecast, by Component
- 7.3.5.8.3. Market size and forecast, by Demography
- 7.3.5.8.4. Market size and forecast, by End User
- 7.3.5.9. Sweden
- 7.3.5.9.1. Key market trends, growth factors and opportunities
- 7.3.5.9.2. Market size and forecast, by Component
- 7.3.5.9.3. Market size and forecast, by Demography
- 7.3.5.9.4. Market size and forecast, by End User
- 7.3.5.10. Denmark
- 7.3.5.10.1. Key market trends, growth factors and opportunities
- 7.3.5.10.2. Market size and forecast, by Component
- 7.3.5.10.3. Market size and forecast, by Demography
- 7.3.5.10.4. Market size and forecast, by End User
- 7.3.5.11. Finland
- 7.3.5.11.1. Key market trends, growth factors and opportunities
- 7.3.5.11.2. Market size and forecast, by Component
- 7.3.5.11.3. Market size and forecast, by Demography
- 7.3.5.11.4. Market size and forecast, by End User
- 7.3.5.12. Rest of Europe
- 7.3.5.12.1. Key market trends, growth factors and opportunities
- 7.3.5.12.2. Market size and forecast, by Component
- 7.3.5.12.3. Market size and forecast, by Demography
- 7.3.5.12.4. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Component
- 7.4.3. Market size and forecast, by Demography
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Component
- 7.4.5.1.3. Market size and forecast, by Demography
- 7.4.5.1.4. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Component
- 7.4.5.2.3. Market size and forecast, by Demography
- 7.4.5.2.4. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Component
- 7.4.5.3.3. Market size and forecast, by Demography
- 7.4.5.3.4. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Component
- 7.4.5.4.3. Market size and forecast, by Demography
- 7.4.5.4.4. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Component
- 7.4.5.5.3. Market size and forecast, by Demography
- 7.4.5.5.4. Market size and forecast, by End User
- 7.4.5.6. New Zealand
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Component
- 7.4.5.6.3. Market size and forecast, by Demography
- 7.4.5.6.4. Market size and forecast, by End User
- 7.4.5.7. Philippines
- 7.4.5.7.1. Key market trends, growth factors and opportunities
- 7.4.5.7.2. Market size and forecast, by Component
- 7.4.5.7.3. Market size and forecast, by Demography
- 7.4.5.7.4. Market size and forecast, by End User
- 7.4.5.8. Rest of Asia-Pacific
- 7.4.5.8.1. Key market trends, growth factors and opportunities
- 7.4.5.8.2. Market size and forecast, by Component
- 7.4.5.8.3. Market size and forecast, by Demography
- 7.4.5.8.4. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Component
- 7.5.3. Market size and forecast, by Demography
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Component
- 7.5.5.1.3. Market size and forecast, by Demography
- 7.5.5.1.4. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Component
- 7.5.5.2.3. Market size and forecast, by Demography
- 7.5.5.2.4. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Component
- 7.5.5.3.3. Market size and forecast, by Demography
- 7.5.5.3.4. Market size and forecast, by End User
- 7.5.5.4. Venezuela
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Component
- 7.5.5.4.3. Market size and forecast, by Demography
- 7.5.5.4.4. Market size and forecast, by End User
- 7.5.5.5. Argentina
- 7.5.5.5.1. Key market trends, growth factors and opportunities
- 7.5.5.5.2. Market size and forecast, by Component
- 7.5.5.5.3. Market size and forecast, by Demography
- 7.5.5.5.4. Market size and forecast, by End User
- 7.5.5.6. Rest of LAMEA
- 7.5.5.6.1. Key market trends, growth factors and opportunities
- 7.5.5.6.2. Market size and forecast, by Component
- 7.5.5.6.3. Market size and forecast, by Demography
- 7.5.5.6.4. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
- CHAPTER 9: COMPANY PROFILES
- 9.1. Medtronic plc
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
- 9.2. Abbott Laboratories
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. DexCom, Inc.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
- 9.4. Senseonics
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Key strategic moves and developments
- 9.5. Johnson & Johnson
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.6. A. Menarini Diagnostics S.r.l
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.7. Novo Nordisk A/S
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.8. GlySens Incorporated
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.9. Ypsomed AG
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.10. F. Hoffman-La Roche Ltd
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- LIST OF TABLES
- TABLE 01. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 02. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY REGION, 2021-2031 ($MILLION)
- TABLE 03. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY REGION, 2021-2031 ($MILLION)
- TABLE 04. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 05. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 06. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 07. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 08. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 09. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 13. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 14. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 15. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 17. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 18. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 19. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 20. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 21. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 22. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 24. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 25. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 26. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 27. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 28. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 30. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 31. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 32. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 33. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 34. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 35. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 36. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 37. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 39. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 40. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 41. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 42. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 43. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 44. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 45. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 46. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 48. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 49. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 50. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 51. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 52. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 53. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 54. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 55. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 56. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 57. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 58. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 59. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 60. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 61. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 62. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 63. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 64. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 65. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 66. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 67. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 68. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 69. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 70. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 71. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 73. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 74. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 76. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 77. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 78. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 79. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 80. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 82. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 83. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 85. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 86. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 87. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 88. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 89. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 90. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 91. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 92. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 93. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 94. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 95. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 96. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 97. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 98. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 99. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 100. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 101. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 102. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 103. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 104. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 105. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 106. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 107. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 108. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 109. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 110. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 111. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 112. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 113. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
- TABLE 114. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 115. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 116. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 117. MEDTRONIC PLC: PRODUCT SEGMENTS
- TABLE 118. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 119. MEDTRONIC PLC: KEY STRATERGIES
- TABLE 120. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 121. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 122. ABBOTT LABORATORIES: PRODUCT SEGMENTS
- TABLE 123. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 124. ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 125. DEXCOM, INC.: KEY EXECUTIVES
- TABLE 126. DEXCOM, INC.: COMPANY SNAPSHOT
- TABLE 127. DEXCOM, INC.: PRODUCT SEGMENTS
- TABLE 128. DEXCOM, INC.: PRODUCT PORTFOLIO
- TABLE 129. DEXCOM, INC.: KEY STRATERGIES
- TABLE 130. SENSEONICS: KEY EXECUTIVES
- TABLE 131. SENSEONICS: COMPANY SNAPSHOT
- TABLE 132. SENSEONICS: PRODUCT SEGMENTS
- TABLE 133. SENSEONICS: PRODUCT PORTFOLIO
- TABLE 134. SENSEONICS: KEY STRATERGIES
- TABLE 135. JOHNSON & JOHNSON: KEY EXECUTIVES
- TABLE 136. JOHNSON & JOHNSON: COMPANY SNAPSHOT
- TABLE 137. JOHNSON & JOHNSON: PRODUCT SEGMENTS
- TABLE 138. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
- TABLE 139. A. MENARINI DIAGNOSTICS S.R.L: KEY EXECUTIVES
- TABLE 140. A. MENARINI DIAGNOSTICS S.R.L: COMPANY SNAPSHOT
- TABLE 141. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT SEGMENTS
- TABLE 142. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT PORTFOLIO
- TABLE 143. NOVO NORDISK A/S: KEY EXECUTIVES
- TABLE 144. NOVO NORDISK A/S: COMPANY SNAPSHOT
- TABLE 145. NOVO NORDISK A/S: PRODUCT SEGMENTS
- TABLE 146. NOVO NORDISK A/S: PRODUCT PORTFOLIO
- TABLE 147. GLYSENS INCORPORATED: KEY EXECUTIVES
- TABLE 148. GLYSENS INCORPORATED: COMPANY SNAPSHOT
- TABLE 149. GLYSENS INCORPORATED: PRODUCT SEGMENTS
- TABLE 150. GLYSENS INCORPORATED: PRODUCT PORTFOLIO
- TABLE 151. YPSOMED AG: KEY EXECUTIVES
- TABLE 152. YPSOMED AG: COMPANY SNAPSHOT
- TABLE 153. YPSOMED AG: PRODUCT SEGMENTS
- TABLE 154. YPSOMED AG: PRODUCT PORTFOLIO
- TABLE 155. F. HOFFMAN-LA ROCHE LTD: KEY EXECUTIVES
- TABLE 156. F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 157. F. HOFFMAN-LA ROCHE LTD: PRODUCT SEGMENTS
- TABLE 158. F. HOFFMAN-LA ROCHE LTD: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031
- FIGURE 02. SEGMENTATION OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031
- FIGURE 03. TOP INVESTMENT POCKETS IN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022-2031)
- FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05. LOW BARGAINING POWER OF BUYERS
- FIGURE 06. LOW THREAT OF SUBSTITUTES
- FIGURE 07. LOW THREAT OF NEW ENTRANTS
- FIGURE 08. LOW INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
- FIGURE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY COUNTRY 2021-2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY COUNTRY 2021-2031(%)
- FIGURE 13. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY COUNTRY 2021-2031(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY COUNTRY 2021-2031(%)
- FIGURE 16. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY 2021-2031(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY COUNTRY 2021-2031(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
- FIGURE 20. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY REGION, 2021
- FIGURE 21. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 22. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 24. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 25. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 26. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 27. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 28. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 29. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
- FIGURE 30. NETHERLANDS CONTINUOUS GLUCOSE MON
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook